Science
Innocan Pharma’s Breakthrough: Diabetic Foot Relief Treatment Demonstrates Remarkable Efficacy
Unlocking Market Potential: Innocan Pharma's Breakthrough Cream Shows Promise in Diabetic Foot Care
Nuvectis Pharma Reports Q1 Results, Expects Several Clinical Updates in H2 2024
Nuvectis Chairman & CEO Ron Bentsur: “2024 is shaping up to be a potentially transformational year for Nuvectis with several clinical data updates expected in the second half of the year.”
No More Content





